Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Not applicable Status: Unknown status Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20142
20181
20192
20201
20223
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
American University of Beirut Medical Center1
Amsterdam UMC, location VUmc1
Firat University1
Fondazione Don Carlo Gnocchi ETS1
Imam Abdulrahman Bin Faisal University1
Institut Pasteur1
Institute for Clinical Research1
University Hospital Muenster1
University Hospital of Mont-Godinne1
University of Aarhus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting15
Multiple Sclerosis7
Demyelinating Diseases2
Multiple Sclerosis, Chronic Progressive2
Ataxia1
Autoimmune Diseases1
Erectile Dysfunction1
Fatigue1
Inflammation1
Mobility Limitation1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.